Details of the Drug

General Information of Drug (ID: DMFMZC9)

Drug Name

mRNA-1195

Indication

Disease Entry	ICD 11	Status	REF
Epstein barr virus infection	1C80	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05831111) A Phase 1, Randomized, Observer-Blind, Placebo-Controlled, 2-Part, Dose-Ranging Study of an EBV Candidate Vaccine, mRNA-1195, in Healthy Adults 18 to 55 Years of Age. U.S.National Institutes of Health.